Literature DB >> 15372276

1alpha,25(OH)(2)D(3) regulates NF-kappaB DNA binding activity in cultured normal human keratinocytes through an increase in IkappaBalpha expression.

Jette L Riis1, Claus Johansen, Borbala Gesser, Kristine Møller, Christian G Larsen, Knud Kragballe, Lars Iversen.   

Abstract

NF-kappaB is a dimeric transcription factor which regulates transcription of a number of different genes including IL-8 and p53. In resting cells NF-kappaB is usually retained in an inactive state in the cytoplasm through binding to a member of the inhibitory kappaB (IkappaB) protein family. The purpose of this study was to determine the effect of 1alpha,25(OH)(2)D(3) on NF-kappaB activation in both unstimulated and stimulated (IL-1alpha) cultured normal human keratinocytes. NF-kappaB DNA binding activity was determined by EMSA using two different oligonucleotides containing the kappaB sequence from either the IL-8 or the p53 promoter. IkappaBalpha and p53 expression was determined by Western blotting and IL-8 expression by ELISA. In unstimulated keratinocytes no NF-kappaB binding to the IL-8 kappaB binding sequence was detectable, whereas stimulation with IL-1alpha (10 ng/ml) led to a significant ( P<0.05) induction of NF-kappaB binding. In contrast NF-kappaB binding to the p53 kappaB binding sequence was detectable in unstimulated cells, although it was significantly increased after IL-1alpha (10 ng/ml) stimulation. Incubation with 1alpha,25(OH)(2)D(3) (10(-8)-10(-7) M) was shown to significantly ( P<0.05) stimulate the expression of IkappaBalpha and in parallel experiments with normal human keratinocytes stimulated with IL-1alpha (10 ng/ml) a significant ( P<0.05) time and dose-dependent decrease in NF-kappaB binding to the IL-8 kappaB binding sequence and in IL-8 expression were seen. A less-pronounced decrease in NF-kappaB binding to the p53 kappaB response element was seen after preincubation with 1alpha,25(OH)(2)D(3) and IL-1alpha stimulation, and it did not result in any change in p53 expression. These results demonstrate that 1alpha,25(OH)(2)D(3) inhibits NF-kappaB binding to the IL-8 kappaB binding sequence more potently than binding to the p53 kappaB binding sequence. We propose that this selectivity may be mediated through an increased expression of IkappaBalpha which leads to an inhibition of specific NF-kappaB subunits resulting in a selective regulation of NF-kappaB-induced gene transcription.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15372276     DOI: 10.1007/s00403-004-0509-9

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  27 in total

1.  1,25-Dihydroxyvitamin D₃ suppresses inflammation-induced expression of plasminogen activator inhibitor-1 by blocking nuclear factor-κB activation.

Authors:  Yunzi Chen; Juan Kong; Tao Sun; George Li; Frances L Szeto; Weicheng Liu; Dilip K Deb; Youli Wang; Qun Zhao; Ravi Thadhani; Yan Chun Li
Journal:  Arch Biochem Biophys       Date:  2010-12-19       Impact factor: 4.013

2.  20,23-dihydroxyvitamin D3, novel P450scc product, stimulates differentiation and inhibits proliferation and NF-kappaB activity in human keratinocytes.

Authors:  Zorica Janjetovic; Robert C Tuckey; Minh N Nguyen; Edwin M Thorpe; Andrzej T Slominski
Journal:  J Cell Physiol       Date:  2010-04       Impact factor: 6.384

3.  Vitamin D3 inhibits TNFα-induced latent HIV reactivation in J-LAT cells.

Authors:  G Nunnari; P Fagone; F Lazzara; A Longo; D Cambria; G Di Stefano; M Palumbo; L Malaguarnera; Michelino Di Rosa
Journal:  Mol Cell Biochem       Date:  2016-06-13       Impact factor: 3.396

4.  Vitamin D attenuates pro-inflammatory TNF-α cytokine expression by inhibiting NF-кB/p65 signaling in hypertrophied rat hearts.

Authors:  Nawal M Al-Rasheed; Nouf M Al-Rasheed; Yieldez A Bassiouni; Iman H Hasan; Maha A Al-Amin; Hanaa N Al-Ajmi; Raeesa A Mohamad
Journal:  J Physiol Biochem       Date:  2015-05-01       Impact factor: 4.158

Review 5.  Extraskeletal actions of vitamin D.

Authors:  Daniel D Bikle
Journal:  Ann N Y Acad Sci       Date:  2016-07       Impact factor: 5.691

6.  Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state.

Authors:  Sif Hansdottir; Martha M Monick; Nina Lovan; Linda Powers; Alicia Gerke; Gary W Hunninghake
Journal:  J Immunol       Date:  2009-12-11       Impact factor: 5.422

7.  Vitamin D receptor deletion leads to reduced level of IkappaBalpha protein through protein translation, protein-protein interaction, and post-translational modification.

Authors:  Shaoping Wu; Yinglin Xia; Xingyin Liu; Jun Sun
Journal:  Int J Biochem Cell Biol       Date:  2009-11-30       Impact factor: 5.085

Review 8.  Vitamin D and human health: lessons from vitamin D receptor null mice.

Authors:  Roger Bouillon; Geert Carmeliet; Lieve Verlinden; Evelyne van Etten; Annemieke Verstuyf; Hilary F Luderer; Liesbet Lieben; Chantal Mathieu; Marie Demay
Journal:  Endocr Rev       Date:  2008-08-11       Impact factor: 19.871

9.  Vitamin D receptor inhibits nuclear factor κB activation by interacting with IκB kinase β protein.

Authors:  Yunzi Chen; Jing Zhang; Xin Ge; Jie Du; Dilip K Deb; Yan Chun Li
Journal:  J Biol Chem       Date:  2013-05-13       Impact factor: 5.157

10.  Vitamin D analogs differentially control antimicrobial peptide/"alarmin" expression in psoriasis.

Authors:  Mark Peric; Sarah Koglin; Yvonne Dombrowski; Katrin Gross; Eva Bradac; Amanda Büchau; Andreas Steinmeyer; Ulrich Zügel; Thomas Ruzicka; Jürgen Schauber
Journal:  PLoS One       Date:  2009-07-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.